Abstract: The present invention provides PBP2a peptide antigens for generating antibodies against MRSA, and provides high-affinity binding agents that detect MRSA by selective immunoreactivity with PBP2a. The antibodies are useful in methods and systems for detecting MRSA, including biosensor systems, or as components of diagnostic or detection kits. The antibodies, in some embodiments, have therapeutic value against MRSA infection.
Type:
Grant
Filed:
May 7, 2009
Date of Patent:
May 27, 2014
Assignee:
Innovative Biosensors, Inc.
Inventors:
Colette Cote, Qiao-xi Zheng, Venkatakrishna Shyamala, Tom Hazel
Abstract: The present invention provides PBP2a peptide antigens for generating antibodies against MRSA, and provides high-affinity binding agents that detect MRSA by selective immunoreactivity with PBP2a. The antibodies are useful in methods and systems for detecting MRSA, including biosensor systems, or as components of diagnostic or detection kits. The antibodies, in some embodiments, have therapeutic value against MRSA infection.
Type:
Application
Filed:
May 7, 2009
Publication date:
October 13, 2011
Applicant:
Innovative Biosensors, Inc.
Inventors:
Colette Cote, Qiao-Xi Zheng, Venkatakrishna Shyamala, Tom Hazel